Cutis Laxa Gene Panel
Test Overview
The Cutis Laxa Gene Panel is a molecular genetic test used to identify pathogenic or likely pathogenic variants in genes associated with cutis laxa and related connective-tissue disorders. These conditions may cause loose, sagging skin along with abnormalities involving the blood vessels, lungs, gastrointestinal tract, bones, or other organs.
Why is this test performed?
- Evaluation of suspected inherited cutis laxa
- Identification of the genetic cause of unexplained loose or inelastic skin
- Assessment of associated connective-tissue or multisystem abnormalities
- Confirmation of a suspected clinical diagnosis
- Family counseling and assessment of recurrence risk
- Supporting appropriate clinical and genetic management
What does the test detect?
The panel analyzes selected genes associated with cutis laxa and related phenotypes for genetic variants that may contribute to disease. Depending on the laboratory's panel design, analysis may include single-nucleotide variants, small insertions/deletions, and selected copy-number changes.
Sample Required
Usually EDTA whole blood is used. Sample requirements may vary according to the laboratory's testing protocol.
Test Method
Next-Generation Sequencing (NGS), with appropriate variant confirmation and/or copy-number analysis where applicable.
Interpretation
Results are classified according to established variant-interpretation guidelines. A detected pathogenic or likely pathogenic variant may help establish a molecular diagnosis, while a negative result does not completely exclude a genetic disorder.
Important Note
Genetic testing should be interpreted together with the patient's clinical findings, family history, and other investigations. Genetic counseling may be recommended before and after testing.
Keywords: Cutis Laxa, Genetic Testing, NGS, Connective Tissue Disorder, Hereditary Disorder, Molecular Genetics, Gene Panel, Variant Analysis
